The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Regulatory News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.65
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (2.778%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.65
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

14 Jun 2007 07:01

Fabian Romania Property Fund Ltd14 June 2007 Fabian Romania Property Fund Limited ("Fabian Romania" or the "Fund") Fabian Romania announces the acquisition of an €8.0 million office developmentscheme in Bucharest Fabian Romania has signed a turn-key agreement with Hil Construct to purchaseits sixth office project in central Bucharest for a prospective purchase yieldof 8.9 per cent.. Completion is conditional on the attainment of the finalbuilding permit which is currently expected at the end of August 2007. The Romana office building will be built for the Fund on a centrally locatedsite on Dacia Boulevard. The building will be built to Class A specificationswith a gross area of approximately 3,000 square metres ("sqm"). The projectmanagement will be undertaken by Globus, an experienced local developer inRomania. Construction is due to commence in the fourth quarter 2007 withcompletion anticipated in the third quarter of 2009. Total construction costsare estimated to be in the order of €8.0 million. Upon completion, the building will provide a net lettable office area of around2,480 sqm over 7 floors, together with 40 car parking spaces. The building is ina prominent position with views over Plaza Romana and is likely to attractinternational tenants seeking Class A office space. Vacancy rates for Class Aoffice space in in Bucharest are less than 3 per cent.. The Fund, advised by itsinvestment manager Fabian Capital Limited ("Fabian Capital"), will assume theletting responsibility for the building. The estimated rental value of thebuilding upon completion is €715,000 per annum giving a prospective purchaseyield of 8.9 per cent.. Upon completion the Fund will pay the purchase price of €7.6 million to Hil in 3instalments; a first instalment of €2.0 million will be made for the company toacquire ownership of the land; a second instalment for construction costs ofapproximately €3.0 million; and a final payment upon practical completion of€2.6 million in the form of a bank guarantee. Including non developer relatedcosts, the total purchase price is forecast to be €8.0 million. The Fund'sequity requirement is expected to be €2 million with debt finance to fund thebalance. Dacia Boulevard is in the heart of Bucharest running between Calle Victoria andRomana Square. It is some 5 minutes by car from the Intercontinental Hotel. Thisarea is a popular office location. A number of international companies havetheir headquarters nearby. Commenting on the transaction, Mark Owen, Property Director of Fabian Capital,said: "We are pleased the Fund has signed another high quality office purchase shortlyafter the announcement of its intention to purchase the Evocenter. This newdevelopment is located in one of the most central positions you could hope toachieve in Bucharest and we are confident the Fund will achieve pre lets priorto completion. The building is flexible to provide sub 1,000 sqm floor plates ofwhich there is an under supply in the market whilst still otherwise providingClass A technical specifications. This investment will make it the third in thecentral core area of Bucharest for the Funds' expanding Portfolio." The lead advisers on the transaction were DTZ (property agent), WSP (technicaladvisers) and Tuca (legal adviser). For Comments:Fabian Romania:Mark Holdsworth +44 20 7499 9988 Nominated Adviser:Deloitte & Touche LLPJames Lewis +44 20 7936 3000 Broker:Shore Capital Stockbrokers LimitedDru Danford +44 20 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Jan 20232:05 pmRNSSecond Price Monitoring Extn
9th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 202311:05 amRNSSecond Price Monitoring Extn
9th Jan 202311:00 amRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSHalf-year Report
24th Nov 20227:00 amRNSNotice of Results
31st Oct 20221:47 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSBlock admission six monthly return
23rd Sep 202211:44 amRNSResult of AGM
20th Sep 20221:36 pmRNSDirector/PDMR Shareholding
15th Sep 20223:41 pmRNSGrant of options
14th Sep 20222:05 pmRNSSecond Price Monitoring Extn
14th Sep 20222:01 pmRNSPrice Monitoring Extension
6th Sep 20227:00 amRNSGrant of options
1st Sep 20227:00 amRNSNotice of AGM and Director change
23rd Aug 20227:00 amRNSFinal Results
9th Aug 20227:00 amRNSBispecific designs patent application
5th Aug 20224:41 pmRNSSecond Price Monitoring Extn
5th Aug 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSAppointment of Chief Executive Officer
6th May 20227:00 amRNSTrading update
1st Apr 20227:00 amRNSBlock admission six monthly return
14th Mar 20227:00 amRNSUpdate on Board changes
28th Feb 20227:00 amRNSDirector changes
22nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20224:35 pmRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSDirectorate Change
10th Feb 202212:49 pmRNSStmnt re Share Price Movement
14th Jan 20227:00 amRNSFormation of New Scientific Advisory Panel
11th Jan 20221:26 pmRNSHolding(s) in Company
31st Dec 20217:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSExercise of share options and total voting rights
14th Dec 20217:00 amRNSExercise of share options and total voting rights
6th Dec 20217:00 amRNSHalf-year Report
2nd Dec 20217:00 amRNSUpdate on R&D
17th Nov 202110:00 amRNSNotice of Results
19th Oct 20214:25 pmRNSGrant of options
7th Oct 20214:40 pmRNSSecond Price Monitoring Extn
7th Oct 20214:35 pmRNSPrice Monitoring Extension
7th Oct 20212:06 pmRNSSecond Price Monitoring Extn
7th Oct 20212:00 pmRNSPrice Monitoring Extension
7th Oct 202111:06 amRNSSecond Price Monitoring Extn
7th Oct 202111:00 amRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSNew contract win
27th Sep 20217:00 amRNSTotal Voting Rights
24th Sep 202112:00 pmRNSResult of AGM
24th Sep 20217:00 amRNSAGM Statement
1st Sep 20217:00 amRNSNotice of AGM
31st Aug 20215:00 pmRNSTotal Voting Rights
24th Aug 20217:00 amRNSCollaboration with Eurofins Discovery

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.